Navigation Links
Dr. Peter C. Neligan, Author of 3rd Edition of Elsevier's Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
Date:11/27/2012

PHILADELPHIA, Nov. 27, 2012 /PRNewswire/ -- In the wake of the passing of Nobel Prize winning surgeon Dr. Joseph Murray, who carried out the first successful kidney transplant in 1954, Dr. Peter C. Neligan, author of the definitive textbook of the discipline, Plastic Surgery, (3rd Ed., Elsevier, October 2012) is available to comment on Dr. Murray's legacy of innovation. Dr. Murray died on Monday in Boston at the age of 93.

"The history of Plastic Surgery is one of innovation in medicine, and Dr. Murray's contributions paved the way for developments that today continue in areas such as hand and face transplantation," says Dr. Neligan, author of five books, more than 50 book chapters and 170 peer-reviewed papers.

A professor of Plastic Surgery and Otolaryngology/Neck Surgery at the University of Washington Medical Center in Seattle, Dr. Neligan spent four years editing Plastic Surgery, working with the Elsevier team and with the volume editors. The 6-volume text is the first update in a decade, and includes 160 videos and online resources that bring the latest techniques to the practitioner's iPad or cell phone.

"Many people think of plastic surgery as a cosmetic practice, but Aesthetic Surgery fills only one of the six volumes in the Plastic Surgery text," Dr. Neligan says. "Plastic Surgeons are leading the way with new developments in stem cell therapy, tissue engineering, and inductive therapies; aesthetic surgical techniques and nonsurgical treatments; conjoined twin separation and other craniofacial surgery advances; microsurgical lymphatic reconstruction, super microsurgery, nerve transfers in hand surgery, functional prosthetics, and more."

Additional information about Dr. Neligan and Plastic Surgery is available at http://elsevierauthors.com/peterneligan.



'/>"/>
SOURCE Elsevier, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
2. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
3. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
4. Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
5. Swiss, EMA, US Pharmacopoeia and World Health Organization Authorities to Provide an Update on Cool Chain Regulations
6. Auditors Complete Kansas Bioscience Authority Forensic Audits
7. Dietary Supplements Extensively Regulated, Say Authors of New Article
8. Fitzsimons Redevelopment Authority Names New President & CEO
9. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
10. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
11. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Cover in the Medical, Dental & Related Services/Trade Category
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
Breaking Biology Technology:
(Date:6/9/2016)... ISTANBUL , June 9, 2016  Perkotek an innovation leader in attendance control ... to seamlessly log work hours, for employers to make sure the right employees are ... Logo - http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):